SCHEMBL24933635

SCHEMBL24933635

C=C1COCc2c1cnn2Cc1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 10/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
MCHR1 Q99705 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
UCHL1 P09936 1/20 0.38
TOP2A P11388 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38
TUBB6 Q9BUF5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933626 0.85 NPBWR1 (0.50) NPBWR1SMN1; SMN2MCHR1MEN1KMT2A
SCHEMBL6837137 0.73 NPBWR1 (0.51) NPBWR1MCHR1MEN1KMT2ATOP2A
SCHEMBL6837344 0.73 NPBWR1 (0.53) NPBWR1MCHR1MEN1KMT2ATOP2A
SCHEMBL25184150 0.72 NPBWR1 (0.49) NPBWR1MCHR1MEN1KMT2ATOP2A
SCHEMBL25521018 0.72 NPBWR1 (0.49) NPBWR1MCHR1MEN1KMT2AUCHL1
SCHEMBL24933636 0.71 NPBWR1 (0.41) NPBWR1SMN1; SMN2MCHR1UCHL1SIGMAR1
SCHEMBL30875225 0.69 NPBWR1 (0.49) NPBWR1MCHR1MEN1KMT2ATOP2A
SCHEMBL30875221 0.69 NPBWR1 (0.49) NPBWR1MCHR1MEN1KMT2ATOP2A
SCHEMBL15182489 0.69 CYP11B2 (0.52) NPBWR1MCHR1MEN1KMT2AUCHL1
SCHEMBL6837345 0.69 NPBWR1 (0.49) NPBWR1MCHR1MEN1KMT2ATOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed